Riskpilot← Back to searchSign inGet full accessVital Way AB
ABActiveOrg 5590944897Mössebergsparken 2Business and other management consultancy activities · NACE 7020Est. 20161 employees
Revenue 2025
SEK 2,8M
+450% vs 2024
EBITDA margin
49.7%
+1172% vs 2024
Equity ratio
52.2%
Financial strength
Net profit 2025
SEK 754K
+1033% vs 2024
| Revenue | SEK 2,8M | +450% |
| EBITDA | SEK 1,4M | +1172% |
| Net profit | SEK 754K | +1033% |
| Total assets | SEK 2M | +468% |
| Equity | SEK 1M | +279% |
| Employees | 1 | — |
Legal name
Vital Way AB
Org number
5590944897
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
28 december 2016
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva konsultationer och strategisk planering inom företagssektorn, idka öppen hälso- och sjukvård utan läkare, idka handel med värdepapper samt därmed förenlig verksamhet.
Address
Mössebergsparken 2
Email
bhiladvala@live.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 577 | 1 394 | 1 558 | 504 | 2 772 |
| Staff expenses | — | −1 182 | −1 086 | −537 | −1 182 |
| EBITDA | 250 | −104 | 212 | −128 | 1 377 |
| Depreciation & amort. | −6 | −6 | −6 | −6 | −147 |
| EBIT | 244 | −110 | 206 | −134 | 1 230 |
| Net financials | −2 | −0 | 0 | 0 | 4 |
| Profit before tax | 179 | −4 | 153 | −81 | 937 |
| Tax | −38 | −3 | −33 | — | −183 |
| Net profit | 141 | −7 | 120 | −81 | 754 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 884 | 478 | 815 | 345 | 1 963 |
| Equity | 338 | 231 | 351 | 270 | 1 024 |
| Long-term debt | 0 | — | — | — | 60 |
| Short-term debt | 441 | 247 | 411 | 75 | 582 |
| Total debt | 441 | 247 | 411 | 75 | 642 |
EBITDA margin
49.7%
This company
15.8%
Market median
+215% vs market
20212025
Equity ratio
52.2%
This company
38.2%
Market median
+37% vs market
20212025
Return on equity
73.6%
This company
18.4%
Market median
+300% vs market
20212025
Net profit margin
27.2%
This company
8.1%
Market median
+236% vs market
20212025
Asset turnover
1.41×
This company
1.12×
Market median
+26% vs market
20212025
Debt / equity
0.92×
This company
0.62×
Market median
+48% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JS Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2020 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Vital Way AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jal Soli Bhiladvala | Chief Executive Officer | 0 companies |
| Sebastian Sven Soli Bhiladvala | Deputy Board Member | 0 companies |
| G K Charlotte Rogestedt Bhiladvala | Chairman | 0 companies |
| Anna Gunilla Elisabet Rogestedt | Deputy Board Member | 0 companies |